|
Stegemann began his professional career at the Ontario Cancer Institute studying molecular modeling and dynamics. He then worked briefly in engineering research and development at Lurgi GmbH in Frankfurt, Germany, where he studied chemical process design. In 1990, Stegemann returned to the University of Toronto to pursue a master’s degree in bioengineering. He then spent five years working for Boston-based W.R. Grace & Co. (later called Circe Biomedical), where his work focused on cell-based bioartificial organs. In 1997, he returned to academia to earn his doctorate degree from the Department of Biomedical Engineering at the Georgia Institute of Technology in Atlanta. Stegemann joined Rensselaer’s biomedical engineering department following his graduation in 2002.
In 2004, Stegemann earned a James D. Watson Investigator Program award from the New York State Office of Science, Technology, and Academic Research (NYSTAR). He also received the Young Investigator Award from the International Society for Applied Cardiovascular Biology in 2002.
An active member of Committee F04 - Tissue Engineered Medical Products of the American Society for Testing and Materials since 1998, Stegemann also has served as Chair of Subcommittee F04.43 on Cells and Tissue Engineered Constructs and on other subcommittees. His professional contributions also include serving as a manuscript/grant reviewer for chemical and biomaterial publications, as well as for the National Science Foundation, NASA, and Singapore Biomedical Research Council (A*STAR).
Stegemann is a member of the American Association for the Advancement of Science (AAAS), the American Chemical Society (ACS), the Biomedical Engineering Society (BMES), and the Society for Biomaterials (SFB). | 